NAVLIMETOSTAT
UNII UHN5PKM648

Substance Identification & Data

This profile provides standardized clinical and technical data for Navlimetostat, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UHN5PKM648.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2630904-45-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

UHN5PKM648

CAS Registry Number

2630904-45-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NAVLIMETOSTAT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H18ClFN6O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BZKIOORWZAXIBA-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C215286

National Cancer Institute reference terminology for clinical and research data.

INN ID

13484

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(c(n(nc1)C)-c2c(c(Cl)cc(c2C#N)OC3CC3)F)-c4cc5c(n[nH]c(c5cc4)=O)CN

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Navlimetostat. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.